Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F86652036%3A_____%2F15%3A00464077" target="_blank" >RIV/86652036:_____/15:00464077 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/61388971:_____/15:00464077

  • Výsledek na webu

    <a href="http://dx.doi.org/10.1007/s13238-015-0194-9" target="_blank" >http://dx.doi.org/10.1007/s13238-015-0194-9</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s13238-015-0194-9" target="_blank" >10.1007/s13238-015-0194-9</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)

  • Popis výsledku v původním jazyce

    Prostate secretory protein 94 (PSP94), a dominant protein of human seminal plasma known also as β-microseminoprotein (MSMB), has recently been shown to decrease serum level expression during prostate cancer (PC) progression and indicated as a novel promising serum oncomarker with a predictive role in PC diagnosis. In this work we aimed to generate a novel class of protein binders targeted to human PSP94 that can serve as robust capture proteins for improved PC diagnostics. We used high-complex combinatorial library derived from an albumin-binding domain (ABD) scaffold of streptococcal protein G with a theoretical complexity up to 2 x 1014 protein variants and ribosome display to generate a plasmid library of selected variants. Individual clones were characterized by binding of ABD-derived proteins to recombinant PSP94 and sequentially compared and characterized. Collection of 35 ABD-derived protein binders of human PSP94 (called PAB binders), corresponding to 29 different sequence variants, was generated. PAB036, PAB046 and PAB050 were identified as the most promising binding candidates characterized in ELISA. Their stability was verified by thermal shift assay and the binding affinity to the recombinant PSP94 was estimated by microscale thermophoresis. These PAB variants bound to PSP94-expressing human LNCaP prostate carcinoma cells and this binding was dose-dependently inhibited by recombinant PSP94. Thus, we generated a unique collection of novel proteins binders of human PSP94 that can serve as a valuable tool for human PSP94 detection and, with a further modification, as high-affinity capture proteins for the development of biosensors for more complex PC diagnostics.

  • Název v anglickém jazyce

    Novel binders derived from an albumin-binding domain scaffold targeting human prostate secretory protein 94 (PSP94)

  • Popis výsledku anglicky

    Prostate secretory protein 94 (PSP94), a dominant protein of human seminal plasma known also as β-microseminoprotein (MSMB), has recently been shown to decrease serum level expression during prostate cancer (PC) progression and indicated as a novel promising serum oncomarker with a predictive role in PC diagnosis. In this work we aimed to generate a novel class of protein binders targeted to human PSP94 that can serve as robust capture proteins for improved PC diagnostics. We used high-complex combinatorial library derived from an albumin-binding domain (ABD) scaffold of streptococcal protein G with a theoretical complexity up to 2 x 1014 protein variants and ribosome display to generate a plasmid library of selected variants. Individual clones were characterized by binding of ABD-derived proteins to recombinant PSP94 and sequentially compared and characterized. Collection of 35 ABD-derived protein binders of human PSP94 (called PAB binders), corresponding to 29 different sequence variants, was generated. PAB036, PAB046 and PAB050 were identified as the most promising binding candidates characterized in ELISA. Their stability was verified by thermal shift assay and the binding affinity to the recombinant PSP94 was estimated by microscale thermophoresis. These PAB variants bound to PSP94-expressing human LNCaP prostate carcinoma cells and this binding was dose-dependently inhibited by recombinant PSP94. Thus, we generated a unique collection of novel proteins binders of human PSP94 that can serve as a valuable tool for human PSP94 detection and, with a further modification, as high-affinity capture proteins for the development of biosensors for more complex PC diagnostics.

Klasifikace

  • Druh

    J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

  • CEP obor

    EB - Genetika a molekulární biologie

  • OECD FORD obor

Návaznosti výsledku

  • Projekt

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2015

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Protein & Cell

  • ISSN

    1674-800X

  • e-ISSN

  • Svazek periodika

    6

  • Číslo periodika v rámci svazku

    10

  • Stát vydavatele periodika

    CN - Čínská lidová republika

  • Počet stran výsledku

    6

  • Strana od-do

    774-779

  • Kód UT WoS článku

    000362653100010

  • EID výsledku v databázi Scopus